Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot Syndrome. | MicrobiomeTrials← Back to trialsNCT06843122
Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot Syndrome.
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-03-05Est. Completion: 2027-02-28
Enrollment target: 105 participants Locations- Szpital Bielanski Im.Ks.Jerzego Popieluszki Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Warsaw, Poland
Other microbiome trials you might be interested in
Diabetic Foot Ulcer
Diabetic foot ulcer is a common and disabling complication of diabetes mellitus. This randomized controlled trial will b…
Muzaffarabad, PakistanEst. completion May 2027
Diabetic Foot Ulcers (DFUs)
Real world evidence study on the performance and safety of a nitric oxide generating dressing on the treatment of diabet…
Ashton-under-Lyne, United KingdomEst. completion Sep 2027